Metastatic adamantinoma responds to treatment wit... [Acta Oncol. 2010] - PubMed

Related citations

Tyrosine kinase inhibitors in treatment of fibrous histiocytoma. [Exp Oncol. 2009]
Tyrosine kinase inhibitors in treatment of fibrous histiocytoma.
Mauri D, Panou C, Valachis A, Kamposioras K, Tsali L. Exp Oncol. 2009 Mar; 31(1):60-1.
Sunitinib malate and multiple receptor tyrosine kinases inhibitors: are they also novel drugs for chronic and neurophatic pain? [J Clin Oncol. 2007]
Sunitinib malate and multiple receptor tyrosine kinases inhibitors: are they also novel drugs for chronic and neurophatic pain?
Di Lorenzo L. J Clin Oncol. 2007 Jul 1; 25(19):2858-9; author reply 2859-61.
Review Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors. [Clin Ther. 2007]
Review Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors.
Adams VR, Leggas M. Clin Ther. 2007 Jul; 29(7):1338-53.
Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. [Clin Cancer Res. 2003]
Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies.
London CA, Hannah AL, Zadovoskaya R, Chien MB, Kollias-Baker C, Rosenberg M, Downing S, Post G, Boucher J, Shenoy N, et al. Clin Cancer Res. 2003 Jul; 9(7):2755-68.
Review [Lung cancer: molecular targeting therapy]. [Nihon Kokyuki Gakkai Zasshi. 2004]
Review [Lung cancer: molecular targeting therapy].
Kobayashi K. Nihon Kokyuki Gakkai Zasshi. 2004 May; 42(5):371-7.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Metastatic adamantinoma responds to treatment with receptor tyrosine kinase inh...
Metastatic adamantinoma responds to treatment with receptor tyrosine kinase inhibitor.
Acta Oncol. 2010 ;49(1):101-4.

PubMed
Spider silks and their applications.
Spider silks and their applications.
Trends Biotechnol. 2008 May ;26(5):244-51. Epub 2008 Mar 25 .

PubMed
The National Open Disclosure Pilot: evaluation of a policy implementation initia...
The National Open Disclosure Pilot: evaluation of a policy implementation initiative.
Med J Aust. 2008 Apr 7 ;188(7):397-400.

PubMed
Acute dyspnea in the office.
Acute dyspnea in the office.
Am Fam Physician. 2003 Nov 1 ;68(9):1803-10.

PubMed
[The protective effects of Lycium barbarum polysaccharide on alloxan-induced iso...
[The protective effects of Lycium barbarum polysaccharide on alloxan-induced isolated islet cells damage in rats].
Zhong Yao Cai. 2002 Sep ;25(9):649-51.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Metastatic adamantinoma responds to treatment with receptor tyrosine kinase inhibitor.

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information